Sustaining Circulating Regulatory T Cell Subset Contributes to the Therapeutic Effect of Paroxetine on Mice With Diabetic Cardiomyopathy

• Published in: Circulation Journal Vol. 84; no. 9; pp. 1587 - 1598
• Main Authors: Han, Yongsheng, Lai, Jiacheng, Tao, Juan, Tai, Yu, Zhou, Weijie, Guo, Paipai, Wang, Zhen, Wang, Manman, Wang, Qingtong
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Circulation Society 25.08.2020
• Subjects: Diabetic cardiomyopathy; G protein coupled receptor kinase 2; Heart function; Regulatory T cell; Th17; Diabetic cardiomyopathy; G protein coupled receptor kinase 2; Heart function; Th17; Regulatory T cell
• ISSN: 1346-9843; 1347-4820
• DOI: 10.1253/circj.CJ-19-1182

Background:G protein coupled receptor kinase 2 (GRK2) inhibitor, paroxetine, has been approved to ameliorate diabetic cardiomyopathy (DCM). GRK2 is also involved in regulating T cell functions; the potential modifications of paroxetine on the immune response to DCM is unclear.Methods and Results:DCM mouse was induced by high-fat diet (HFD) feeding. A remarkable reduction in the regulatory T (Treg) cell subset in DCM mouse was found by flow cytometry, with impaired cardiac function evaluated by echocardiography. The inhibited Treg differentiation was attributable to insulin chronic stimulation in a GRK2-PI3K-Akt signaling-dependent manner. The selective GRK2 inhibitor, paroxetine, rescued Treg differentiation in vitro and in vivo. Furthermore, heart function, as well as the activation of excitation-contraction coupling proteins such as phospholamban (PLB) and troponin I (TnI) was effectively promoted in paroxetine-treated DCM mice compared with vehicle-treated DCM mice. Blockade of FoxP3 expression sufficiently inhibited the proportion of Treg cells, abolished the protective effect of paroxetine on heart function as well as PLB and TnI activation in HFD-fed mice. Neither paroxetine nor carvedilol could effectively ameliorate the metabolic disorder of HFD mice.Conclusions:The impaired systolic heart function of DCM mice was effectively improved by paroxetine therapy, partially through restoring the population of circulating Treg cells by targeting the GRK2-PI3K-Akt pathway.